it's time to get on folks lol, page-94

re: just released very positive sirtex news The analysis was the analysts will recommend the share at $4 for the run to a higher number based on accelerating growth rates due to expansions of indications that are beginning to be enumerated in news. It seems to be that the analysts are sleeping here as if the Sir Spheres can be used conjointlly with multiple different chemotherapeutics and in multiple different tumor types that have metastasized to the liver then Sirtex at market cap of 82 million USD with a market potential that is in the billions is very undervalued and shares can leap with float of only 8 million shares. BY Dr Gray, HH and instos controlling 83 % of share they can be quite confident that they will be determing price of acquisition and the acquisition itself. The valuation of $ 8.71 USD was demonstrated on one of the earlier notes.